Lateral Flow Device Aspergillus Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study
Lateral-Flow-Device-Antigentestung auf Aspergillus im Routineeinsatz zur Diagnose der invasiven pulmonalen Aspergillose bei kritisch kranken Patient:innen: multizentrische Kohortenstudie auf Intensivstationen
Open Forum Infectious Diseases · 28.04.2025 · 12 (5)
DOI: 10.1093/ofid/ofaf256 ↗Auf einen Blick
Bei 180 ICU-Patient:innen war der BAL-Lateral-Flow-Device-Test für probable IPA diagnostisch gut. Sensitivität und Spezifität lagen bei 71 % bzw. 98 %.
Fragestellung
Wie gut diagnostiziert der bronchoalveoläre Lavage-Lateral-Flow-Device-Test eine probable invasive pulmonale Aspergillose bei kritisch kranken ICU-Patient:innen?
Methode
Retrospektive multizentrische Kohortenstudie in 9 Behandlungszentren; 180 ICU-Patient:innen; Klassifikation nach FUNDICU-Kriterien.
Ergebnisse
48 Patient:innen hatten probable IPA, 132 dienten als Kontrollen. Sensitivität 71 % (95 %-KI 56 %–83 %), Spezifität 98 % (94 %–100 %), AUC 0,84. Positiver LR 31,17, negativer LR 0,30.
Einschränkungen
Nicht ausreichend, um IPA sicher auszuschließen.
Schlussfolgerung der Autor:innen
Der Lateral-Flow-Device-Test kann in zeitkritischen ICU-Situationen zur schnellen Diagnose von IPA nützlich sein. Zum sicheren Ausschluss der Erkrankung reicht er allein nicht aus.
Kernaussagen
- BAL-LFD: Sensitivität 71 %, Spezifität 98 %
- AUC 0,84 für die Diagnostik
- Allein kein sicherer Ausschluss von IPA
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 29.04.2025. Verfasst von Stefan Hatzl und 4 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
The incidence of invasive pulmonary aspergillosis (IPA) is rising among intensive care unit (ICU) patients, with early diagnosis and treatment being critical for survival. Lateral flow assays for Aspergillus antigen detection have recently been introduced, enabling rapid results within an hour and potentially supporting earlier clinical decision making and timely antifungal therapy.
Methods
This retrospective multicenter study included 180 ICU patients, 48 with IPA and 132 controls, across 9 treatment centers. Fungal infections were classified according to the FUNDICU criteria (Invasive Fungal Diseases in Adult Patients in Intensive Care Unit).
Results
Among the 180 patients, 48 were classified as having probable IPA, while 132 exhibited host factors and radiologic findings consistent with IPA but did not meet the FUNDICU criteria. In this cohort, the sensitivity and specificity of the bronchoalveolar lavage lateral flow device test for diagnosing probable IPA vs no IPA were 71% (95% CI, 56%–83%) and 98% (94%–100%), respectively. The area under the receiver operating characteristic curve was 0.84, indicating good diagnostic performance. The positive and negative likelihood ratios were 31.17 (10.03–96.80) and 0.30 (.19–.46), yielding a diagnostic odds ratio of 104 (30–360). The positive and negative predictive values were 92% (78%–98%) and 90% (84%–95%).
Conclusions
Lateral flow device testing may serve as a valuable tool for the rapid diagnosis of IPA in time-critical ICU settings. However, it is not sufficient to definitively rule out the disease, and a comprehensive diagnostic approach remains essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Intensive Care Unit, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- BioTechMed Graz, Graz, Austria.
- Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
ORCID-Profile: Stefan Hatzl, Lisa Kriegl, Christina Geiger, Philipp Eller, Robert Krause
Zitieren
APA
Hatzl, S., Kriegl, L., Geiger, C., Eller, P., & Krause, R. (2025). Lateral Flow Device Aspergillus Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study. Open Forum Infectious Diseases, 12(5). https://doi.org/10.1093/ofid/ofaf256
Vancouver
Hatzl S, Kriegl L, Geiger C, Eller P, Krause R. Lateral Flow Device Aspergillus Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study. Open Forum Infectious Diseases. 2025;12(5). doi:10.1093/ofid/ofaf256
BibTeX
@article{Hatzl2025,
author = {Hatzl, Stefan and Kriegl, Lisa and Geiger, Christina and Eller, Philipp and Krause, Robert},
title = {Lateral Flow Device Aspergillus Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {5},
doi = {10.1093/ofid/ofaf256}
}
EUVIMED